These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 3543696)
1. Pay-as-you-go trials anger government cancer researchers. Beardsley T Nature; 1987 Jan 8-14; 325(7000):99. PubMed ID: 3543696 [No Abstract] [Full Text] [Related]
2. In business to treat cancer. Henig RM N Y Times Mag; 1986 Nov; ():68, 70, 78, 80+. PubMed ID: 11647805 [No Abstract] [Full Text] [Related]
3. Multicenter trials and subject eligibility: should local IRBs play a role? Freedman B IRB; 1994; 16(1-2):1-6. PubMed ID: 11652320 [No Abstract] [Full Text] [Related]
4. Forum on prisoners' access to clinical trials: summary of recommendations. Stein GL; Headley LD AIDS Public Policy J; 1996; 11(1):3-20. PubMed ID: 10915234 [No Abstract] [Full Text] [Related]
5. The IRB's role in assessing the generalizability of non-NIH-funded clinical trials. Weijer C IRB; 1998; 20(2-3):1-5. PubMed ID: 11656912 [No Abstract] [Full Text] [Related]
6. Are clinical trials of cell transplantation for Duchenne muscular dystrophy ethical? Cho MK IRB; 1994; 16(1-2):12-5. PubMed ID: 11652321 [No Abstract] [Full Text] [Related]
7. The paradoxical case of payment as benefit to research subjects. Macklin R IRB; 1989; 11(6):1-3. PubMed ID: 11650284 [No Abstract] [Full Text] [Related]
8. The exclusion of pregnant, pregnable, and once-pregnable people (a.k.a. women) from biomedical research. Merton V Am J Law Med; 1993; 19(4):369-451. PubMed ID: 7942864 [TBL] [Abstract][Full Text] [Related]
9. An IRB member's perspective on access to innovative therapy. Moore DL Albany Law Rev; 1994; 57(3):559-81. PubMed ID: 11652854 [No Abstract] [Full Text] [Related]
10. The changing clinical trials scene: the role of the IRB. Mitchell SC; Steingrub J IRB; 1988; 10(4):1-5. PubMed ID: 11650078 [No Abstract] [Full Text] [Related]
11. Protection of human subjects. United States Code Fed Regul Shipping; 1982 Oct; Part 46, Sections 46.101 to 46.306():. PubMed ID: 11660819 [No Abstract] [Full Text] [Related]
12. FDA's new rule on treatment use and sale of investigational new drugs. Levine RJ IRB; 1987; 9(4):1-4. PubMed ID: 11649946 [No Abstract] [Full Text] [Related]
13. Paying for patient care in treatment research--who is responsible? Wittes RE Cancer Treat Rep; 1987 Feb; 71(2):107-13. PubMed ID: 3100033 [No Abstract] [Full Text] [Related]
14. Research with children. Glantz LH Am J Law Med; 1998; 24(2-3):213-44. PubMed ID: 9702273 [No Abstract] [Full Text] [Related]
15. Exclusion of pregnant women from research protocols: unethical and illegal. Hall JK IRB; 1995; 17(2):1-3. PubMed ID: 11653053 [No Abstract] [Full Text] [Related]
16. In search of funding: the clinical investigator and the drug company; Commentary: why researchers need not be demoralized. Siris ES; Burrell CD IRB; 1983; 5(6):1-5. PubMed ID: 11649526 [No Abstract] [Full Text] [Related]
17. Women as research subjects. American College of Clinical Pharmacy. Pharmacotherapy; 1993; 13(5):534-42. PubMed ID: 8247929 [No Abstract] [Full Text] [Related]
18. Clinical studies with make-believe drugs. Lewis JP West J Med; 1992 Dec; 157(6):677-8. PubMed ID: 1475961 [No Abstract] [Full Text] [Related]
19. Money is putting people at risk in biomedical research. Andrews LB Chron High Educ; 2000 Mar; 46(27):B1, B4-5. PubMed ID: 11657699 [No Abstract] [Full Text] [Related]
20. Emergency trials 'by popular consent. Kiernan V New Sci; 1995 Nov; 148(2002):6. PubMed ID: 11656475 [No Abstract] [Full Text] [Related] [Next] [New Search]